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oTATE-OF-THE-ART PAPER91Hypertensive Heart Diseaseubha V. Raman
aman reviews the pathology and prognostic implications of the changes in cardiac structure
nd function seen with chronic hypertension. The clinical sequelae include higher rates of
eart failure, arrhythmias, and ischemic events. The histologic features include myocyte hy-
ertrophy, expansion of interstitial and perivascular collagen, and changes in intramyocar-
ial capillary density and arteriolar thickening. The utility of various imaging modalities
s reviewed including the possibility of quantifying myocardial fibrosis with cardiovascular
agnetic resonance and imaging alterations in cellular metabolism. Finally, the clinical
ignificance of structural changes in the aorta and the left atrium are reviewed.TATE-OF-THE-ART PAPER97Transcatheter Aortic Valve Implantation for Failing Bioprosthetic Valvesuhammed Z. Khawaja, Peter Haworth, Azad Ghuran, Lorraine Lee, Adam de Belder,
eville Hutchinson, Uday Trivedi, Jean-Claude Laborde, David Hildick-Smith
hawaja and colleagues report a case series of 4 patients who had previously undergone aortic
alve replacement (AVR) with a bioprosthetic valve that subsequently failed. All of the
ubjects were poor candidates for open repair because of comorbidities and, therefore,
nderwent transcatheter aortic valve implantation (TAVI) using the CoreValve System
Medtronic, Luxembourg). All procedures were technically successful, with immediate
mprovements in valvular hemodynamics and no periprocedural deaths. The authors speculate
hat these patients may be ideal candidates for TAVI because the sewing ring of the
ioprosthetic valve provides a rigid support to anchor the new valve, which decreases the risks
f perivalvular regurgitation and valve migration.(continued on page A-24)
JANUARY 12, 2010 (continued) A-24A
ICLINICAL RESEARCHE
T
I
i
i
d
e
s
T
s
p
r
c
E
A
E
A
L
a
i
r
a
r
b
a
tCUTE MYOCARDIAL INFARCTION
102mmediate Versus Delayed Angioplasty
for STEMI Patients Who Receive Thrombolysisllen Bøhmer, Pavel Hoffmann, Michael Abdelnoor, Harald Arnesen, Sigrun Halvorsen
he NORDISTEMI (NORwegian study on DIstrict treatment of ST-Elevation Myocardial
nfarction) trial compared a strategy of immediate transfer for percutaneous coronary
ntervention (PCI) to an ischemia-guided approach in ST-segment elevation myocardial
nfarction (STEMI) patients who initially received thrombolysis because of very long transfer
istances to PCI-capable facilities. All subjects were treated with tenecteplase, aspirin,
noxaparin, and clopidogrel, and were then randomized to immediate transfer for PCI or to
tandard management with early transfer only for clinical deterioration or rescue indication.
here was no significant reduction in the primary end point (composite of death, reinfarction,
troke, or new ischemia within 12 months), but when new ischemia, which was a soft end
oint, was excluded the hazard ratio was 0.36, favoring immediate transfer for PCI. These
esults suggest that patients who receive thrombolysis benefit by being transferred to a PCI-
apable facility.ditorial Comment: Jeremy W. Buckley, Brahmajee K. Nallamothu, p. 111SPIRIN RESISTANCE114Omega-3 Fatty Acids May Be Effective for Treating Aspirin Resistanceli I. Lev, Alejandro Solodky, Naama Harel, Aviv Mager, David Brosh, Abid Assali, Milton Roller,
lexander Battler, Neal S. Kleiman, Ran Kornowski
ev and colleagues hypothesized that the addition of omega-3 fatty acids might ameliorate
spirin resistance by decreasing the availability of platelet arachidonic acid (AA) and,
ndirectly, thromboxane A2 formation. Thirty subjects who had aspirin resistance were
andomized to either low-dose aspirin plus omega-3 fatty acids (4 capsules daily) or high-dose
spirin (325 mg) daily. Following 30 days of treatment, there were significant and similar
eductions in AA- and ADP-induced aggregation and the VerifyNow Aspirin assay score in
oth groups. These results suggest that aspirin-resistant patients can be treated either by
dding omega-3 fatty acids or increasing the aspirin dose, but a large clinical trial is necessary
o determine which method is superior.(continued on page A-28)
JANUARY 12, 2010 (continued) A-28SM
Y
R
K
d
S
s
I
t
T
t
b
b
E
P
S
Z
i
m
s
c
i
a
l
E
Y
T
G
i
b
g
s
b
sUDDEN DEATH122Morphology of Plaques and Thrombus That Lead to SCDiranda C. A. Kramer, Saskia Z. H. Rittersma, Robbert J. de Winter, Elena R. Ladich, David R. Fowler,
ou-Hui Liang, Robert Kutys, Naima Carter-Monroe, Frank D. Kolodgie, Allard C. van der Wal,
enu Virmani
ramer and colleagues reviewed medical examiner cases of sudden coronary death (SCD) to
etermine which types of atherosclerotic plaque lead to coronary thrombosis and then to
CD. Over 100 cases in which coronary thrombosis was the likely cause of death were
tudied in detail, including the histology of the plaque and the components of the thrombus.
n the majority of cases, SCD did not follow suddenly upon thrombus formation, with many
hrombi in the “infiltrating” or “healing” stage, suggesting that they were at least 4 days old.
he severity of stenosis, the necrotic core size, and the total plaque burden were all greater in
he ruptured plaque group. Erosions tended to have older, healing thrombi. The differences
etween plaque erosions and ruptures suggest the possibility that erosions and ruptures should
e treated differently.ditorial Comment: Richard I. Levin, p. 133PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH135Gdf5 Regulates Cardiac Repair After InfarctionTWOK
2mmyed H. E. Zaidi, Qingling Huang, Abdul Momen, Ali Riazi, Mansoor Husain
aidi and colleagues studied the function of the protein growth differentiation factor 5 (Gdf5)
n a mouse model of myocardial infarction (MI). Gdf5-knockout (KO) and wild type (WT)
ice were subjected to permanent left anterior descending coronary artery ligation. WT mice
howed increased cardiac Gdf5 levels post-MI, with increased expression in peri-infarct
ardiomyocytes and myofibroblasts. By 28 days post-MI, Gdf5-KO mice exhibited increased
nfarct scar area, increased left ventricular dilation, and decreased contractility. Gdf5-KO mice
lso exhibited increased cardiomyocyte apoptosis. Increased expression of Gdf5 post-MI may
imit infarct scar expansion and help to reduce cardiac remodeling.ditorial Comment: Georg Ertl, Thomas Thum, p. 144YEAR IN CARDIOLOGY SERIES EAR IN CARDIOLOGY SERIES147The Year in Congenital Heart Diseasehomas P. Graham, Jr
raham reviewed the literature for papers describing the results of surgical or catheter-based
nterventions for patients with congenital heart disease. The papers are divided into sections
y the pathologic condition, including tetralogy of Fallot, Fontan surgery, transposition of the
reat arteries, hypoplastic left heart syndrome, aortic valve surgery, aortoplasty, and ventricular
eptal defect management. The 32 papers summarized in these particular areas were chosen
ecause of the importance to the general field of congenital heart disease and provide a brief
ummary for the interested reader.
